Literature DB >> 15026028

Prostacyclin and endothelium-dependent hyperpolarization.

Helena C Parkington1, Harold A Coleman, Marianne Tare.   

Abstract

Prostacyclin released from the endothelium is capable of relaxing vascular smooth muscle. Here, we review the mechanisms underpinning this relaxation, with a focus on the role of smooth muscle hyperpolarization. The contribution of endothelium-derived prostacyclin to overall blood pressure is discussed. The role of prostacyclin in determining vasodilation in different vascular beds, especially in relation to sex steroid status and in pregnancy, is also discussed. Interactions between prostacyclin and other endothelium-derived vasodilators are reviewed. The synthetic pathway for prostanoid production, including prostacyclin, is upregulated in many diseases and drugs that interfere with this pathway are in widespread use. Emerging information suggests that these drugs may impact on endothelial prostacyclin production, with less than optimal consequences for thrombus formation and vasodilation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026028     DOI: 10.1016/j.phrs.2003.11.012

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  32 in total

1.  Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells.

Authors:  Qi Liu; Yutao Xi; Toya Terry; Shui-Ping So; Anita Mohite; Jia Zhang; Geru Wu; Xiaobing Liu; Jie Cheng; Ke-He Ruan; James T Willerson; Richard A F Dixon
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

Review 2.  Vasodilatory mechanisms of beta receptor blockade.

Authors:  Géraldine Rath; Jean-Luc Balligand; Chantal Dessy; Dessy Chantal
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

Review 3.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

4.  Vascular responses of the extremities to transdermal application of vasoactive agents in Caucasian and African descent individuals.

Authors:  Matthew J Maley; James R House; Michael J Tipton; Clare M Eglin
Journal:  Eur J Appl Physiol       Date:  2015-04-04       Impact factor: 3.078

Review 5.  Endothelium-derived hyperpolarising factors and associated pathways: a synopsis.

Authors:  Gillian Edwards; Michel Félétou; Arthur H Weston
Journal:  Pflugers Arch       Date:  2010-04-11       Impact factor: 3.657

6.  Endothelium-dependent nitric oxide and hyperpolarization-mediated venous relaxation pathways in rat inferior vena cava.

Authors:  Joseph D Raffetto; Peng Yu; Ossama M Reslan; Yin Xia; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2011-12-30       Impact factor: 4.268

Review 7.  Communication Is Key: Mechanisms of Intercellular Signaling in Vasodilation.

Authors:  Julie K Freed; David D Gutterman
Journal:  J Cardiovasc Pharmacol       Date:  2017-05       Impact factor: 3.105

8.  Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.

Authors:  Helen Christou; Hannes Hudalla; Zoe Michael; Evgenia J Filatava; Jun Li; Minglin Zhu; Jose S Possomato-Vieira; Carlos Dias-Junior; Stella Kourembanas; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2017-12-06       Impact factor: 4.030

9.  Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat.

Authors:  Ossama M Reslan; Zongzhi Yin; Graciliano R A do Nascimento; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

10.  Increased constrictor tone induced by ouabain treatment in rats.

Authors:  Victor M Pulgar; Anne B Jeffers; Hanadi M Rashad; Debra I Diz; Azeez A Aileru
Journal:  J Cardiovasc Pharmacol       Date:  2013-08       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.